Request to Join
has invited you to join this group
Dr. Hohnloser holds a position as professor of medicine and cardiology at the J. W. Goethe University in Frankfurt, Germany, where he serves as the head of the division of clinical electrophysiology. His primary research interests focus on risk stratification for and prevention of sudden cardiac death, and pharmacological, antithrombotic, and interventional therapies of atrial fibrillation. Dr. Hohnloser has served as principal investigator or member of the steering committee of many international large randomized clinical trials related to contemporary issues in clinical arrhythmology. He has coauthored almost 400 publications in peer-reviewed journals, 450 abstracts and 50 book chapters. Dr. Hohnloser has been or is currently serving on several committees of the European Society of Cardiology, The European Heart Rhythm Association, and the Heart Rhythm Society.
Dr. Sana Al-Khatib is a tenured Professor of Medicine at Duke University Medical Center (DUMC). She received her M.D. degree from the American University of Beirut and trained in internal medicine, cardiology, and cardiac electrophysiology at DUMC, where she also received her M.H.Sc. degree. Dr. Al-Khatib has expertise and experience in the diagnosis and management of heart rhythm disorders including ventricular arrhythmias and atrial fibrillation. She has focused on the study of rhythm management devices including the implantable cardioverter defibrillator and cardiac resynchronization therapy. She has investigated risk factors, prevention, and treatment of sudden cardiac death (SCD), the leading cause of death in the United States. Dr. Al-Khatib is a board-certified clinical electrophysiologist and an experienced clinical researcher in cardiac arrhythmias. As a graduate of the NIH-funded Clinical Research Training Program, she is one of a few electrophysiologists nation-wide with expertise in quantitative research methods. Her research expertise lies in the design and conduct of clinical trials, outcomes research, and cost-effectiveness analyses. She is a recipient of a National Heart, Lung and Blood Institute’s R-01 grant titled “Implantable Cardioeverter Defibrillator Therapy in Patients with Heart Failure” (2009-2013) and of an American Heart Association Career Development Award (2002-2006). She is a Co-Principal Investigator on an Agency of Healthcare Research and Quality (AHRQ) sponsored R-01 grant titled: “Duke Cardiovascular Center for Education and Research on Therapeutics” and a Co-Principal Investigator on another AHRQ R-01 grant that involves the use of merged patient level data from 12 randomized clinical trials of ICDs. She is a co-Principal Investigator of a National Heart, Lung and Blood Institute T-32 grant for Postdoctoral Training in Cardiovascular Clinical Research. She has close to 190 publications in peer-reviewed journals. Her work has had wide influence on medical research and health policy, the latter being demonstrated by its influence on the Heart Rhythm Society Device Performance Policies and Guidelines. She has served on several professional society committees including the Heart Rhythm Society’s Health Policy committee, the American Heart Association/American College of Cardiology Guideline Development Task Force, and the American College of Cardiology’s ICD Registry Steering committee. She was elected into the American Society for Clinical Investigators (ASCI) in 2013.
Dr. Joseph P. Mathew is the Jerry Reves Professor of Anesthesiology and Chairman of the Department of Anesthesiology at Duke University School of Medicine. Dr. Mathew received his medical degree from Southwestern Medical School in Dallas, TX, and completed his residency in anesthesiology and a fellowship in Cardiovascular Anesthesiology at Yale University School of Medicine. He spent 8 years at Yale University School of Medicine where he served as Associate Professor of Anesthesiology. In 1998, Dr. Mathew joined the faculty at Duke and has since served as Director of Perioperative Transesophageal Echocardiography, Director of the Neurological Outcome Research Group, Chief of the Division of Cardiothoracic Anesthesiology, and most recently as Executive Vice Chair of Performance and Operations for the Department of Anesthesiology. Dr. Mathew is an active physician-scientist funded by the National Institutes of Health for research on perioperative neurocognition and functional brain connectivity, particularly in the setting of cardiac surgery. He has also published extensively on postoperative atrial fibrillation.
Dr. Sundt is the chief of the division of cardiac surgery at the Massachusetts General Hospital and the Edward D Churchill Prof. of surgery at the Harvard Medical School. His clinical focuses cardiac surgery in the adult for acquired cardiovascular disease. He has a long-standing interest in surgery for atrial fibrillation, having taken his cardiac surgical training under James L Cox at Washington University. He has performed the Maze procedure and other arrhythmias operations throughout his career and has published in the P reviewed literature as well as given in divided talks on the subject. He is the author or co-authored of over 300 publications in the peer reviewed literature, 35 book chapters and has delivered hundreds of invited presentations nationally and internationally. He is currently President of the American Association for Thoracic Surgery.